PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33461143-14 2021 Furthermore, DMY could inhibit NF-kappaB/p65 expression, reducing NF-kappaB/p65 translocation to the nucleus to silence Nrf2 signaling, which is necessary for MRP2 expression. dihydromyricetin 13-16 RELA proto-oncogene, NF-kB subunit Homo sapiens 31-44 33461143-14 2021 Furthermore, DMY could inhibit NF-kappaB/p65 expression, reducing NF-kappaB/p65 translocation to the nucleus to silence Nrf2 signaling, which is necessary for MRP2 expression. dihydromyricetin 13-16 RELA proto-oncogene, NF-kB subunit Homo sapiens 41-44 33461143-15 2021 Overexpressing NF-kappaB/p65 expression reduced the reversal effect of DMY. dihydromyricetin 71-74 RELA proto-oncogene, NF-kB subunit Homo sapiens 25-28 27686451-4 2016 Dihydromyricetin was found to markedly inhibit the phosphorylation and degradation of the inhibitor of NF-kappaB alpha (IkappaBalpha), and subsequent nuclear translocation of p65. dihydromyricetin 0-16 RELA proto-oncogene, NF-kB subunit Homo sapiens 175-178 24789439-7 2014 Additionally, DHM significantly induced the apoptosis of SK-MEL-28 cells, and enhanced the expression levels of Bax proteins and decreased the protein levels of IKK-alpha, NF-kappaB (p65) and P-p38. dihydromyricetin 14-17 RELA proto-oncogene, NF-kB subunit Homo sapiens 183-186